EUVIMEDEUVIMED entdecken
Crossref

Utility of First‐Line Diagnostic Tests and Molecular Methods for Accurate Characterization of Sickle Cell Disorders

Diksha Dev Yadav iD, Sanjeev Chhabra iD, Jasbir Kaur Hira, Alka Rani Khadwal iD, Pankaj Malhotra iD, Deepak Bansal iD, Amita Trehan iD, Prashant Sharma iD, Reena Das iD

International Journal of Laboratory Hematology · 2026-06 · 48 (3) · 652-657

DOI: 10.1111/ijlh.70079 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Laboratory Hematology, online erschienen am 01.03.2026. Verfasst von Diksha Dev Yadav und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Molecular Diagnostic Techniques. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: Medical Education & Research Cell, PGIMER.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Sickle cell disorders (SCD) are among the commonest symptomatic hemoglobinopathies worldwide. Their diagnosis involves multiple tests, including complete blood count, cation‐exchange high‐pressure liquid chromatography (CE‐HPLC), hemoglobin electrophoresis, sickling tests, and molecular assays. We evaluated the diagnostic utilities of various testing methods for precise classification of SCDs in a specialist hematology laboratory of a tertiary‐care teaching hospital.

Methods

Clinical, demographic and laboratory data from all SCDs diagnosed between January 2009 and June 2020 using CE‐HPLC, slide‐based sickling test and cellulose acetate electrophoresis were analyzed. Cases with over 50% S‐window peaks on CE‐HPLC were considered for HbS and β‐thalassemia mutation testing. Performance indices of CE‐HPLC, sickling test and electrophoresis were determined in molecularly‐proven SCDs.

Results

The 261 cases with HbS variant included 56% ( n = 147) sickle cell traits (SCT), 21% ( n = 55) Sβ‐thalassemia (Sβ), 17% ( n = 45) sickle cell anemia (SCA), and 5% ( n = 14) HbSD‐Punjab (HbSD Punjab ) cases. Molecular analysis of 71 cases revealed that HbA2 ≥ 4.0% discriminated most efficiently between SCA and Sβ, with 95.2% sensitivity, 96.5% specificity and positive/negative predictive values of 97.5%/93.3%. The commonest β‐thalassemia mutation in Sβ‐thalassemia was HBB :c.92 + 5G>C (58.4%). Alkaline pH electrophoresis and sickling test showed 100% sensitivity. A diagnostic pitfall occurred in PCR‐RFLP due to loss of DdeI restriction site.

Conclusions

Most SCDs encountered in a hospital‐setting are reliably characterized by HPLC and hemogram data, supplemented with the sickling test and, where necessary, parental HPLCs. Molecular analysis aids in accurate characterization of complex cases and in resolution of diagnostic discrepancies; however, their own pitfalls must be borne in mind.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellMolecular Diagnostic TechniquesHumansFemaleHemoglobin, SickleMaleChromatography, High Pressure LiquidAdultMutation

Stichwörter der Autor:innen

HPLCPCR‐RFLPhemoglobinopathymolecular diagnosticssickle cell hemoglobinsodium metabisulfite

Substanzen

Hemoglobin, Sickle

Autor:innen und Institutionen

  • Department of Hematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Department of Clinical Hematology & Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

ORCID-Profile: Diksha Dev Yadav, Sanjeev Chhabra, Alka Rani Khadwal, Pankaj Malhotra, Deepak Bansal, Amita Trehan, Prashant Sharma, Reena Das

Förderung

  • Medical Education & Research Cell, PGIMER

Zitieren

APA

Yadav, D. D., Chhabra, S., Hira, J. K., Khadwal, A. R., Malhotra, P., Bansal, D., Trehan, A., Sharma, P., & Das, R. (2026). Utility of First‐Line Diagnostic Tests and Molecular Methods for Accurate Characterization of Sickle Cell Disorders. International Journal of Laboratory Hematology, 48(3), 652-657. https://doi.org/10.1111/ijlh.70079

Vancouver

Yadav DD, Chhabra S, Hira JK, Khadwal AR, Malhotra P, Bansal D, et al. Utility of First‐Line Diagnostic Tests and Molecular Methods for Accurate Characterization of Sickle Cell Disorders. International Journal of Laboratory Hematology. 2026;48(3):652-657. doi:10.1111/ijlh.70079

BibTeX
@article{Yadav2026,
  author = {Yadav, Diksha Dev and Chhabra, Sanjeev and Hira, Jasbir Kaur and Khadwal, Alka Rani and Malhotra, Pankaj and Bansal, Deepak and Trehan, Amita and Sharma, Prashant and Das, Reena},
  title = {Utility of First‐Line Diagnostic Tests and Molecular Methods for Accurate Characterization of Sickle Cell Disorders},
  journal = {International Journal of Laboratory Hematology},
  year = {2026},
  volume = {48},
  number = {3},
  pages = {652--657},
  doi = {10.1111/ijlh.70079}
}
Kostenlos starten →